Cooper C. Collins, Director at TherapeuticsMD, Inc. (TXMD), sold 2,631,579 shares at $1.75 ($4.6M) on 2013-06-14, disclosed to the SEC on 2013-06-17.
Open-market sale of $4.6M TXMD by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| TXMD | BUY | 2021-11-22 | $580K | — | Filing → |
| TXMD | BUY | 2021-08-19 | $725K | — | Filing → |
| TXMD | BUY | 2020-06-10 | $107K | — | Filing → |